BDBM50328701 (S)-2-(4-(4-chlorophenylsulfonyl)-2-oxopiperazin-1-yl)-N-(5-guanidino-1-oxo-1-(thiazol-2-yl)pentan-2-yl)acetamide::CHEMBL271934

SMILES [#7]\[#6](-[#7])=[#7]\[#6]-[#6]-[#6]-[#6@H](-[#7]-[#6](=O)-[#6]-[#7]-1-[#6]-[#6]-[#7](-[#6]-[#6]-1=O)S(=O)(=O)c1ccc(Cl)cc1)-[#6](=O)-c1nccs1

InChI Key InChIKey=GYTSJVVWEZVUCK-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50328701   

TargetCoagulation factor X(Human)
Johnson & Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50328701((S)-2-(4-(4-chlorophenylsulfonyl)-2-oxopiperazin-1...)
Affinity DataIC50: 2nMAssay Description:Inhibition of human factor 10aMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetProthrombin(Human)
Johnson & Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50328701((S)-2-(4-(4-chlorophenylsulfonyl)-2-oxopiperazin-1...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human alpha-thrombinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Johnson & Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50328701((S)-2-(4-(4-chlorophenylsulfonyl)-2-oxopiperazin-1...)
Affinity DataIC50: 2nMAssay Description:Inhibition of factor 10aMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/2/2013
Entry Details Article
PubMed